Literature DB >> 7508914

Proteolytic conversion of single chain precursor macrophage-stimulating protein to a biologically active heterodimer by contact enzymes of the coagulation cascade.

M H Wang1, T Yoshimura, A Skeel, E J Leonard.   

Abstract

Human serum macrophage stimulating protein (MSP) is a disulfide-linked heterodimer that induces motile and phagocytic activity of mouse resident peritoneal macrophages. It is a member of the family of kringle proteins, which typically exist in extracellular fluid as single chain precursors that are activated by proteolytic cleavage. In this work, we expressed [35S]cysteine-labeled recombinant pro-MSP in MSP cDNA-transfected Chinese hamster ovary cells and studied proteolytic processing of pro-MSP and the requirement of cleavage for biological activity. In media containing heat-inactivated fetal bovine serum, the protein was secreted as single chain pro-MSP, which was cleaved over a period of hours to the mature heterodimer. Cleavage was prevented by serine protease inhibitors such as leupeptin or aprotinin; it did not occur if cells were cultured in serum-free medium. Nanomolar concentrations of coagulation proteases kallikrein, factor XIIa or factor XIa cleaved pro-MSP to MSP within 30 min. Pro-MSP had no biological activity. After cleavage by kallikrein, biological activity was quantitatively comparable to that of natural MSP isolated from human plasma. These results support our hypothesis that MSP circulates as the biologically inactive precursor and can be activated by enzymes of the intrinsic coagulation cascade.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7508914

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Macrophage stimulating protein is a novel neurotrophic factor.

Authors:  M C Stella; A Vercelli; M Repici; A Follenzi; P M Comoglio
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

2.  Hepatocyte growth factor-like protein is a positive regulator of early mammary gland ductal morphogenesis.

Authors:  Devikala Gurusamy; Sasha J Ruiz-Torres; Abby L Johnson; Dana A Smith; Susan E Waltz
Journal:  Mech Dev       Date:  2014-07-15       Impact factor: 1.882

Review 3.  Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.

Authors:  Omid Zarei; Silvia Benvenuti; Fulya Ustun-Alkan; Maryam Hamzeh-Mivehroud; Siavoush Dastmalchi
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-08       Impact factor: 4.553

4.  Biological effects of targeted inactivation of hepatocyte growth factor-like protein in mice.

Authors:  J A Bezerra; T L Carrick; J L Degen; D Witte; S J Degen
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

5.  STK receptor tyrosine kinase regulates susceptibility to infection with Listeria monocytogenes.

Authors:  Michael A Lutz; Francine Gervais; Alan Bernstein; Arthur L Hattel; Pamela H Correll
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

6.  Proteolytic cleavage and activation of pro-macrophage-stimulating protein by resident peritoneal macrophage membrane proteases.

Authors:  M H Wang; A Skeel; E J Leonard
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

Review 7.  MSP-RON signalling in cancer: pathogenesis and therapeutic potential.

Authors:  Hang-Ping Yao; Yong-Qing Zhou; Ruiwen Zhang; Ming-Hai Wang
Journal:  Nat Rev Cancer       Date:  2013-07       Impact factor: 60.716

8.  Epithelial integrity is maintained by a matriptase-dependent proteolytic pathway.

Authors:  Karin List; Peter Kosa; Roman Szabo; Alexandra L Bey; Chao Becky Wang; Alfredo Molinolo; Thomas H Bugge
Journal:  Am J Pathol       Date:  2009-08-28       Impact factor: 4.307

Review 9.  Met-related receptor tyrosine kinase Ron in tumor growth and metastasis.

Authors:  Purnima K Wagh; Belinda E Peace; Susan E Waltz
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

Review 10.  Ron receptor tyrosine kinase signaling as a therapeutic target.

Authors:  Nancy M Benight; Susan E Waltz
Journal:  Expert Opin Ther Targets       Date:  2012-07-26       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.